Eptinezumab Archives - Medical Conferences

PACAP-targeting therapies: a future option for migraine?

Presented By

Dr Zixuan Alice Zhuang, University of Copenhagen, Denmark

Conference

EHC 2024

Type

News article

6 January 2025 11:36

What to do when conventional treatment of headache fails in children

Presented By

Prof. Ishaq Abu-Arafeh, Royal Hospital for Children, Glasgow, UK

Conference

EHC 2022

Type

News article

5 January 2023 11:12

Eptinezumab shows acute benefits during migraine attack

Trial

Phase 3, RELIEF

Conference

EAN 2021

Type

Peer-reviewed article

18 August 2021 10:58

Efficacy and safety of eptinezumab in acute migraine

Trial

Phase 3, RELIEF

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:41

Eptinezumab in chronic migraine and medication-overuse headache

Presented By

Prof. Hans-Christoph Diener, Medical Faculty of the University Duisburg-Essen, Germany

Trial

Phase 3, PROMISE-2

Conference

EAN 2020

Type

Peer-reviewed article

9 September 2020 17:09

Eptinezumab reduces mean monthly migraine days

Trial

Phase 3, PROMISE

Conference

AAN 2019

Type

Peer-reviewed article

30 July 2019 21:35